<< Вернуться к списку статей журнала

Том 2 №1,2 2000 год - Нефрология и диализ

Основные принципы диетотерапии больных хронической почечной недостаточностью, получающих лечение постоянным амбулаторным перитонеальным диализом

Шадур С.С. Вольпян Л.Л.

Аннотация: Мировая практика лечения постоянным амбулаторным перитонеальным диализом (ПАПД) больных хронической почечной недостаточностью (ХПН) неоспоримо доказывает огромное значение питания как фактора успешного лечения и реабилитации этих больных.

Для цитирования: Шадур С.С., Вольпян Л.Л. Основные принципы диетотерапии больных хронической почечной недостаточностью, получающих лечение постоянным амбулаторным перитонеальным диализом. Нефрология и диализ. 2000. 2(1,2):62-69. doi:

Весь текст

Ключевые слова: терминальная ХПН, лечение ПАПД, белково-энергетическая недостаточность, диетотерапия, компоненты диеты

Список литературы:

1. Салтанов А.И., Обухова О. А., Кадырова Э.Г. Оценка питательного статуса в анестезиологии и интенсивной терапии //Вестник интенсивной терапии, 1996, №4, 42-48.
2. Смирнов А.В. Уремическая дислипопротеидемия. Нефрология, 1998; т.2; 2: 15-24.
3. Смирнов А.В., Козлов В.В. Клинические проявления атеросклероза у больных на гемодиализе. Нефрология, 1998; т.2; 2: 68-77.
4. Смирнов А.В. Лечение нефротической и уремической дислипопротеидемий. Нефрология, 1998; т.2; 3: 22-30.
5. Acchiardo S.R., Kraus A.P., Kaufman P.A. et al: Serum albumin a marker for morbidity and mortality in CAPD patients. J Am Soc Nephrol 1993; 4: 396.
6. Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; Vol.39; 169-183.
7. Asayama К., Ito H., Nokahara C.H. et al. Lipid profiles and li-pase activities in children and adolescents with chronic renal failure treated conservatively or with Hemodialysis or transplantation Pediat. Res. 1984; Vol.18; 8: 783-788.
8. Attman P.O. Hyperlipoproteinemia in renal failure: pathogenesis and perspectives for intervention. Nephrol. Dial. Transplant. 1993; Vol. 8; 294-295.
9. Attman P.O., Alaupovic P., Tavella M., Knight-Gibson C. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol. Dial. Transplant. 1996; Vol. 11; 1: 63-69.
10. Attman P.O., Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteidemia - relation to renal function and dialysis. Nephron. 1991; Vol.57; 401-410.
11. Auguet Т., Senty M., Rubies-Prat J. et al. Serum lipoprotein/a/ concentration in patient with chronic renal failure receiving haemodialysis: influence of apolipoprotein/a/ genetic polymorphism. Nephrol. Dial. Transplant. 1993; Vol.8; 10: 1099-1103.
12. Avram M.M., Golwasser P., Burrel D.E. et al. The uremic dislipidemia: a cross-sectional and longitudial study. Amer. J. Kidney Dis. 1992; Vol.20; 4: 324-335.
13. Avram M.M., Golwasser P., Erroa M. et al. Predictors of survival in conti nuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am. J. Kidney Dis. 1994; 23: 91-98.
14. Bannister D.К., Acchiardo S.R., Moore L.W., Kraus A.P. Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis /CAPD/ patients. J. Am. Diet. Ass. 1987; 87: 53-56.
15. Bergstrom J., Furst P., Alvestrand A., Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney lnt.1993; 44; 1048-1057.
16. Blumberg A., Hanck A., Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis/CAPD/. Clin. Nephrol. 1983; 20: 244-250.
17. Blumenkrantz M.J., Gahl G.M., Kopple J.D. et al. Protein losses during peritoneal dialysis. Kidney Int. 1981; 19: 593-602.
18. Blumenkrantz M.J. Nutritional aspects of peritoneal dialysis. - In: Diamond L, Benis J., Deane N. et al. - Proceedings of the Renal Physicians Association: Northeastern Meating, NY. 1979; 3: 29.
19. Blumenkrantz M.J. Nutrition. - In: Handbook of Dialysis. Second Edition, 1994; 374-400.
20. Blumenkrantz M.J., Kopple J.D., Moran J.K., Coburn J.W. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1982; 21; 849-861.
21. Blumenkrantz M.J., Kopple J.D., Moran J.K. et al. Nitrogen and urea metabolizm during continuous ambulatory peritoneal dialysis. Kidney Int. 20; 78-82.
22. Boeschoten E.W., Zuyderhoudt F.M.J., Krediet R.T., Arsz L. Changes in weight and lipid concentrations during CAPD treatment. Periton. Dial. Int. 1988; Vol.8; 1:19-24.
23. Boeschoten E.W., Schrijver J., Krediet R.T., Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol. Dial. Transplant. 1988; 2: 187-193.
24. Bouma S., Dwyer J.T. Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J. Am. Diet Assoc. 1984; 84: 194-197.
25. Breckenridge W.C., Roncary D.A.K., Khanna R., Oreopoulos D.G. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis. 1982; 45: 249-258.
26. DeSantos N.G., Capodicasa G., Senatore T. et al. Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis CAPD.lnt. J. Arif. Org. 1979; 2: 119-124.
27. Dulaney J.T., Hatch F.E. Peritoneal dialysis and loss of proteins: a review. Kidney Int. 1984; 26: 253-262.
28. European Dialysis and Transplant Association - European Renal Association, EDTA/ERA Registry Report, Demography of Dialysis and Transplantation in Europe, 1984; Nephrol. Dial. Transplant. 1986; 1: 1-8.
29. Gokal R., Ramos J.M., McGurk J.G., Ward M.K., Kerr D.N.S. Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. In: Gahl G.M., Kessel M., Nolph K.D. eds. Advances in Peritoneal dialysis. -Amsterdam, Excerpta Medica. 1981; 430-433.
30. Grutzmacher P., Marz W., Peschke B. et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron. 1988; Vol.50; 1: 103-111.
31. Hanning R., Baife J.W., ZIotkins S. Effectiveness and nutritional consequences of amino acids vs glucose-based dialysis solutions in infants and children receiving CAPD. Am. J. Clin. Nutr. 1987; 46: 22-30.
32. Harty J., Gokal R. Nutritional status in peritoneal dialysis. J. Renal Nutr. 1995; Vol. 5; 1: 2-10.
33. Heide В., Pierratos A., Khanna R., Petit J., Ogilvie R. et al. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis CAPD. Perit. Dial. Bull. 1983; 3: 138-141.
34. Henderson I.S., Leung A.C.T., Shenkin A. Vitamin status in continuous ambulatory peritoneal dialysis. Perit. Dial. Bull. 1984; 4: 143-145.
35. Hopkins P.M., Williams R.R. A survey of suggested coronary risk factors. Atherosclerosis. 1981; Vol.40; 1; 1-52.
36. Kaysen G.A. Hyperlipidemia of chronic renal failure. Blood Purific. 1994; Vol.12; 1: 60-67.
37. Kopple J.D., Blumenkrantz M.J., Jones M.R. et al. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am. J. Clin. Nutr. 1982; 36: 395-402.
38. Kopple J.D., Blumenkrantz M.J. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1983; 24 suppl. 16: S295-S302.
39. Krediet R.T., Zuyderhondt F.M.J., Boeschoten E.W., Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis. Nephron. 1986; 42: 133-140.
40. Kurtz S.B., Wong V.H., Anderson C.F. et al. Continuous ambulatory peritoneal dialysis. Three years experience at the Mayo Clinic. Mayo Clin. Proc. 1983; 58: 633-639.
41. Lacour В., Drueke T. Lipid metabolism and endocrine disturbances in uremia. Textbook of nephrology. Ed. Massery S.G., Glassock R.J. 3-rd Ed. 1995; Vol.2; 2025.
42. Lindholm В., Bergstrom J. Nutritional requierments of peritoneal dialysis patients. Textbook of peritoneal dialysis. Ed. Gokal R., Nolph K.D. 1-st Ed. 1994; 443-472.
43. Lindhotm В., Bergstrom J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis CAPD. Clin. Nephrol. 1988; 30: suppl. 1. 859-S63.
44. Mistry C.D., Gokal R. New osmotic agents for peritoneal dialysis: where we are and where we»re going. Semin. Dial. 1990; 4: 9-12.
45. Mitch W.E., Klahr S. Handbook of nutrition and the kidney.3-d Ed. NY. 1998; 384.
46. Nolph K.D., Sorkin M.N., Rubin J. et al. Continuous ambulatory peritoneal dialysis. Three-year experience at one center. Ann. Intern. Med. 1980; 92: 609-613.
47. Oren A., Wu G., Anderson G.H. et al. Effective use of amino acid dialysate over four weeks in CAPD patients. Perit. Dial. Bull. 1983; 3: 66-73.
48. Oreopoulos D.G., Khanna R., McCready W. et al. Continuous ambulatory peritoneal dialysis in Canada. Dial. Transplant. 1980; 9: 224-226.
49. Schilling H., Wu G., Petit J. et al. Nutritional status of patients on long-term CAPD. Perit. Dial. Bull. 1985; 5: 12-18.
50. Schreiber M.J. Clinical tools for assessing the adequacy of peritoneal dialysis /nephrology update/. Cleveland Clinic Foundation. 1990; 1-4.
51. Spiegel D.M., Anderson M., Campbell U. et al. Serum albumin: A marker for morbidity in peritoneal dialysis patients. Am. J. Kidney Dis. 1993; 21: 26-30.
52. Struiik D.G., Krediet R.T., Koomen G.C.M. et al. The effect of serum albumin at the start of CAPD on patient survival. Perit. Dial. Int. 1994; 14: 121-126.
53. Teehan В.P., Schleifer C.R., Brow J.M. et al. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv. Pent. Dial. 1991; 6: 181-185.
54. Traneous A., Heimburger O., Lindholm B. et al. Six years experience of CAPD at one centre: a survey of major findings. Periton. Dial. Int. 1988; 8: 31-41.
55. Tsukamoto Y., Wakabaywshi Y., Okubo M. et al. Abnormal lipid profiles at various stages of uremia. Nephrol. Dial. Transplant. 1989; Vol.4; Suppl. 3. 142-145.
56. Vennegoor M. ed. Nutrition for patients with renal failure. EDNTA -ERCA Publication. 1986; 184.
57. Verger С., Larpent L., Dumontent M. Prognostic value of peritoneal equilibration curves EC in CAPD patients. In: Maher J.F., Winchester J.F. eds, Frontiers in peritoneal dialysis Field Rich and Assoc., Inc., NY. 1986; 88-93.
58. Williams P., Kay R., Harrison J. et al. Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. Perit. Dial. Bull. 1981; 1: 82-87.
59. Young G.A., Brownjohn A.M., Parsons F.M. Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephrol. 1987; 45: 196-201.
60. Young Q.A., Kopple J.D., Lindholm B. et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am. J. Kidney Dis. 1991; 17: 462-471.

Другие статьи по теме

• Нутриционный статус больных на перитонеальном диализе
• Проблемы лечения перитонитов, осложняющих хронический перитонеальный диализ
• Белково-энергетическая недостаточность у больных с терминальной стадией хронической почечной недостаточности, корригируемой различными видами заместительной терапии
• Нетрадиционный метод коррекции белково-энергетической недостаточности у пациентов на программном гемодиализе